J3F-MC-EZCA - ClinicalTrials.gov - NCT04644809
J3F-MC-EZCA - ClinicalTrials.gov - NCT04644809
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have high blood fat levels for Part A and B
Participants must be first generation Japanese origin for Part C
Participants must have a body mass index (BMI) of 18.5 to 40.0 kilograms per square meter (kg/m²)
Male participants must agree to adhere to contraception restrictions and female participants must not be able to get pregnant
Participants must NOT
Participants must not have taken any prescription medications that are for blood fat lowering within the past 2 months (use of statins is allowed if the dose has been stable for 8 weeks)
Participants must not have Type 1 diabetes
Participants must not have currently participated in or completed a clinical trial within the last 30 days
Participants must not be a heavy alcohol drinker or heavy cigarette smoker
Participants must not have donated blood of more than 500 milliliters (mL) in the last 3 months
Trial Summary
Conditions the trial is for
Dyslipidemia
What the trial is testing?
LY3561774
Could I receive a Placebo?
yes
Enrollment Goal
74
Trial Dates
November 2020 - April 2022
Trial Phase
1
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have high blood fat levels for Part A and B
Participants must be first generation Japanese origin for Part C
Participants must have a body mass index (BMI) of 18.5 to 40.0 kilograms per square meter (kg/m²)
Male participants must agree to adhere to contraception restrictions and female participants must not be able to get pregnant
Participants must NOT
Participants must not have taken any prescription medications that are for blood fat lowering within the past 2 months (use of statins is allowed if the dose has been stable for 8 weeks)
Participants must not have Type 1 diabetes
Participants must not have currently participated in or completed a clinical trial within the last 30 days
Participants must not be a heavy alcohol drinker or heavy cigarette smoker
Participants must not have donated blood of more than 500 milliliters (mL) in the last 3 months
Trial Summary
Conditions the trial is for
Dyslipidemia
What the trial is testing?
LY3561774
Could I receive a Placebo?
yes
Enrollment Goal
74
Trial Dates
November 2020 - April 2022
Trial Phase
1
Trial Locations
Hide locations not currently recruiting